Junqiu Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Junqiu Shi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jianzhong Du
East China University of Science and Technology
4 shared publications - Yunqing Zhu
Department of Polymeric Materials Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education School of Materials Science and Engineering Tongji University Shanghai China
4 shared publications - Qingmei Sun
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
3 shared publications - Haiyang Yin
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
1 shared publication - Hui Sun
State Key Laboratory of High-Efficiency Coal Utilization and Green Chemical Engineering, School of Chemistry and Chemical Engineering, Ningxia University, Yinchuan 750021, China
1 shared publication - Jianrui Li
Department of Polymeric Materials, School of Materials Science and Engineering
1 shared publication
Latest Publications
- 2 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (27) , 25466-25479
Reversible Adhesive Hydrogel Balancing Conflicting Needs of Strong Adhesion and Painless Removal for Diabetic Joint Wound Healing
Diabetic joint wounds require dressings with strong adhesion, painless removal, and therapeutic effects. We developed DA-Hyd-Doxy, a multifunctional hydrogel, by copolymerizing N-isopropylacrylamide with dopamine-containing zwitterionic poly(amidoamine)s and encapsulating doxycycline. This hydrogel exhibits strong, reversible adhesion, surpassing the Tegaderm film at ∼35 °C, while exposure to 10 °C water for 10 min reduces adhesion to 0 N for painless removal. It also has antioxidant and anti-inflammatory properties, promoting angiogenesis, collagen deposition, and re-epithelialization. Loaded with doxycycline, it achieves nearly 100% bacteria-killing efficiency against E. coli and S. aureus. In vivo studies showed superior wound healing, with DA-Hyd-Doxy achieving near-complete closure (1.1 ± 0.4%) versus Tegaderm (20.2 ± 3.0%). This hydrogel provides a practical solution for infected diabetic joint wounds, offering strong adhesion, painless removal, and multifunctional therapeutic benefits, making it ideal for dynamic wound sites.
- 2 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (27) , 25466-25479
Reversible Adhesive Hydrogel Balancing Conflicting Needs of Strong Adhesion and Painless Removal for Diabetic Joint Wound Healing
Diabetic joint wounds require dressings with strong adhesion, painless removal, and therapeutic effects. We developed DA-Hyd-Doxy, a multifunctional hydrogel, by copolymerizing N-isopropylacrylamide with dopamine-containing zwitterionic poly(amidoamine)s and encapsulating doxycycline. This hydrogel exhibits strong, reversible adhesion, surpassing the Tegaderm film at ∼35 °C, while exposure to 10 °C water for 10 min reduces adhesion to 0 N for painless removal. It also has antioxidant and anti-inflammatory properties, promoting angiogenesis, collagen deposition, and re-epithelialization. Loaded with doxycycline, it achieves nearly 100% bacteria-killing efficiency against E. coli and S. aureus. In vivo studies showed superior wound healing, with DA-Hyd-Doxy achieving near-complete closure (1.1 ± 0.4%) versus Tegaderm (20.2 ± 3.0%). This hydrogel provides a practical solution for infected diabetic joint wounds, offering strong adhesion, painless removal, and multifunctional therapeutic benefits, making it ideal for dynamic wound sites.
- 24 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (17) , 17014-17027
Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis
Bone diseases, such as bone metastases, pose significant therapeutic challenges due to the distinct physiological environment of skeletal tissues, which complicates the targeted delivery of nucleic acid therapeutics. Existing delivery systems, including lipid nanoparticles (LNP) and polyethylenimine (PEI), struggle to achieve precise bone targeting effectively. To address this issue, we developed a polymer-based bone-targeting bioreducible nucleic acid delivery vector, poly[alendronic acid-co-(N,N'-bis(acryloyl)cystamine-co-4-amino-1-butanol)] (ALN-Pabol), which incorporates alendronic acid (ALN) for precise bone targeting. The ALN-Pabol exhibited a hydroxyapatite binding rate of 91.1%, significantly outperforming nontargeted Pabol/miRNA (73.5%) and commercial systems such as PEI/miRNA (58.3%) and Lipofectamine 2000/miRNA (64.7%). In vivo fluorescence imaging demonstrated its superior skeletal accumulation compared to nontargeted controls. In a murine breast cancer bone metastasis model, ALN-Pabol/miRNA polyplex reduced bone tumor weight by 79.1% relative to PBS controls and 36.8% compared to LNP/miRNA. Mechanistically, the polyplex dissociates in the high-glutathione tumor microenvironment, releasing therapeutic miRNA to suppress cancer cell proliferation and promote apoptosis. Simultaneously, ALN inhibits osteoclast activity, significantly mitigating osteolytic damage. Micro-CT analysis revealed near-complete restoration of bone volume and trabecular architecture to healthy levels. This work establishes ALN-Pabol as a highly promising delivery vector for bone-targeted gene therapy, bridging critical gaps in skeletal disease treatment and expanding potential applications in bone regeneration and cancer therapy.
- 24 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (17) , 17014-17027
Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis
Bone diseases, such as bone metastases, pose significant therapeutic challenges due to the distinct physiological environment of skeletal tissues, which complicates the targeted delivery of nucleic acid therapeutics. Existing delivery systems, including lipid nanoparticles (LNP) and polyethylenimine (PEI), struggle to achieve precise bone targeting effectively. To address this issue, we developed a polymer-based bone-targeting bioreducible nucleic acid delivery vector, poly[alendronic acid-co-(N,N'-bis(acryloyl)cystamine-co-4-amino-1-butanol)] (ALN-Pabol), which incorporates alendronic acid (ALN) for precise bone targeting. The ALN-Pabol exhibited a hydroxyapatite binding rate of 91.1%, significantly outperforming nontargeted Pabol/miRNA (73.5%) and commercial systems such as PEI/miRNA (58.3%) and Lipofectamine 2000/miRNA (64.7%). In vivo fluorescence imaging demonstrated its superior skeletal accumulation compared to nontargeted controls. In a murine breast cancer bone metastasis model, ALN-Pabol/miRNA polyplex reduced bone tumor weight by 79.1% relative to PBS controls and 36.8% compared to LNP/miRNA. Mechanistically, the polyplex dissociates in the high-glutathione tumor microenvironment, releasing therapeutic miRNA to suppress cancer cell proliferation and promote apoptosis. Simultaneously, ALN inhibits osteoclast activity, significantly mitigating osteolytic damage. Micro-CT analysis revealed near-complete restoration of bone volume and trabecular architecture to healthy levels. This work establishes ALN-Pabol as a highly promising delivery vector for bone-targeted gene therapy, bridging critical gaps in skeletal disease treatment and expanding potential applications in bone regeneration and cancer therapy.
- 16 May 2024
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 36 (11) , 5422-5435
Rational Design of Polymeric mRNA Delivery Vectors to Achieve Excellent Room-Temperature Storage Stability and Delivery Efficiency
- 16 May 2024
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 36 (11) , 5422-5435
Rational Design of Polymeric mRNA Delivery Vectors to Achieve Excellent Room-Temperature Storage Stability and Delivery Efficiency
- 16 October 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 24 (11) , 4587-4604
Membrane and Lumen-Compartmentalized Polymersomes for Biocatalysis and Cell Mimics
Compartmentalization is a crucial feature of a natural cell, manifested in cell membrane and inner lumen. Inspired by the cellular structure, multicompartment polymersomes (MCPs), including membrane-compartmentalized polymersomes and lumen-compartmentalized polymersomes (polymersomes-in-polymersomes), have aroused great expectations for biological applications such as biocatalysis and cell mimics in the past decades. Compared with traditional polymersomes, MCPs have advantages in encapsulating multiple enzymes separately for multistep enzymatic cascade reactions. In this review, first, the design principles and preparation methods of membrane-compartmentalized and lumen-compartmentalized polymersomes are summarized. Next, recent advances of MCPs as nanoreactors and cell mimics to mimic subcellular organelles or artificial cells are discussed. Finally, the future research directions of MCPs are prospected.
- 16 October 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 24 (11) , 4587-4604
Membrane and Lumen-Compartmentalized Polymersomes for Biocatalysis and Cell Mimics
Compartmentalization is a crucial feature of a natural cell, manifested in cell membrane and inner lumen. Inspired by the cellular structure, multicompartment polymersomes (MCPs), including membrane-compartmentalized polymersomes and lumen-compartmentalized polymersomes (polymersomes-in-polymersomes), have aroused great expectations for biological applications such as biocatalysis and cell mimics in the past decades. Compared with traditional polymersomes, MCPs have advantages in encapsulating multiple enzymes separately for multistep enzymatic cascade reactions. In this review, first, the design principles and preparation methods of membrane-compartmentalized and lumen-compartmentalized polymersomes are summarized. Next, recent advances of MCPs as nanoreactors and cell mimics to mimic subcellular organelles or artificial cells are discussed. Finally, the future research directions of MCPs are prospected.